Immunohistochemical (CD3+/CD18+) evaluation was consistent with a T-cell lymphoma, which could be classified as a peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS). The gene discussed is ITGB2; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.